Detalhe da pesquisa
1.
Ivosidenib induces deep durable remissions in patients with newly diagnosed IDH1-mutant acute myeloid leukemia.
Blood
; 135(7): 463-471, 2020 02 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-31841594
2.
Durable Remissions with Ivosidenib in IDH1-Mutated Relapsed or Refractory AML.
N Engl J Med
; 378(25): 2386-2398, 2018 Jun 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-29860938
3.
Allogeneic HSCT for adult-onset leukoencephalopathy with spheroids and pigmented glia.
Brain
; 143(2): 503-511, 2020 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31840744
4.
Functional Status as Measured by Geriatric Assessment Predicts Inferior Survival in Older Allogeneic Hematopoietic Cell Transplantation Recipients.
Biol Blood Marrow Transplant
; 26(1): 189-196, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31493541
5.
Limitation in Patient-Reported Function Is Associated with Inferior Survival in Older Adults Undergoing Autologous Hematopoietic Cell Transplantation.
Biol Blood Marrow Transplant
; 25(6): 1218-1224, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30708189
6.
Outcomes of allogeneic transplantation after hypomethylating agents with venetoclax in acute myeloid leukemia.
Am J Hematol
; 97(6): E191-E194, 2022 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35266185
7.
Quantification of Acute Lymphoblastic Leukemia Clonotypes in Leukapheresed Peripheral Blood Progenitor Cells Predicts Relapse Risk after Autologous Hematopoietic Stem Cell Transplantation.
Biol Blood Marrow Transplant
; 22(6): 1030-1036, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-26899561
8.
Multigene Measurable Residual Disease Assessment Improves Acute Myeloid Leukemia Relapse Risk Stratification in Autologous Hematopoietic Cell Transplantation.
Biol Blood Marrow Transplant
; 22(11): 1974-1982, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27544285
9.
How I treat CNS lymphomas.
Blood
; 122(14): 2318-30, 2013 Oct 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-23963042
10.
Venetoclax monotherapy for cutaneous blastic plasmacytoid dendritic cell neoplasm.
Ann Hematol
; 99(12): 2973-2975, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32968828
11.
Hypomethylating agents super-responders: challenging the dogma of long-term remission for acute myeloid leukemia.
Ann Hematol
; 99(6): 1411-1413, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32377815
12.
Improved outcomes of octogenarians and nonagenarians with acute myeloid leukemia in the era of novel therapies.
Am J Hematol
; 95(11): E305-E308, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32744731
13.
p53 immunohistochemistry as an ancillary tool for rapid assessment of residual disease in TP53-mutated acute myeloid leukemia and myelodysplastic syndromes.
Am J Clin Pathol
; 2024 Apr 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38643353
14.
Association of geriatric measures and global frailty with cognitive decline after allogeneic hematopoietic cell transplantation in older adults.
J Geriatr Oncol
; 14(8): 101623, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37678052
15.
Standardising acute myeloid leukaemia classification systems: a perspective from a panel of international experts.
Lancet Haematol
; 10(9): e767-e776, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37572683
16.
Patterns and Predictors of Functional Decline after Allogeneic Hematopoietic Cell Transplantation in Older Adults.
Transplant Cell Ther
; 28(6): 309.e1-309.e9, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35247612
17.
Paraproteinemic keratopathy as the presenting sign of hematologic malignancy.
Am J Hematol
; 91(9): 961-2, 2016 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26872417
18.
The transfusion tether: Bridging the gap between end-stage hematologic malignancies and optimal end-of-life care.
Am J Hematol
; 91(4): 364-5, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-26799788
19.
Measurable residual disease status and FLT3 inhibitor therapy in patients with FLT3-ITD mutated AML following allogeneic hematopoietic cell transplantation.
Bone Marrow Transplant
; 56(12): 3091-3093, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34584238
20.
Epstein-Barr virus-positive lymphoproliferative disorder manifesting as pulmonary disease in a patient with acute myeloid leukemia: a case report.
J Med Case Rep
; 15(1): 170, 2021 Mar 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-33773605